Fibrocor Therapeutics
PrivateLast Round
Strategic
Jan 15, 2020
Total Funding Raised
$2.1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Fibrocor Therapeutics operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Strategic round in January 2020.
Fibrocor Therapeutics is a biotechnology company that develops first-in-class therapeutics targeting fibrotic diseases, with an initial focus on kidney diseases such as Alport Syndrome and ADPKD.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fibrocor Therapeutics Comparables
Compare Fibrocor Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evotec | 80% | |
| Mirador Therapeutics | 80% | |
| ENYO Pharma | 78% |
For institutional investors. Book with your work email.
Fibrocor Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jan 15, 2020 | ||||
| Seed | Jan 17, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Fibrocor Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TIAP | Seed |
| BioGeneration Ventures | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 282% MoM, reaching 2.5K.
- Jan 15, 2020
Raised capital from BioGeneration Ventures and Lakefront Biotherapeutics NV.
For institutional investors. Book with your work email.
Fibrocor Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Fibrocor Therapeutics's valuation, stock price, and market status.
Is Fibrocor Therapeutics a public or private company?
Fibrocor Therapeutics is a private company.
What is the current stock price of Fibrocor Therapeutics?
Fibrocor Therapeutics is a private company, so its shares have no public market price. Caplight tracks Fibrocor Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fibrocor Therapeutics worth (valuation)?
Valuation information for Fibrocor Therapeutics is not publicly available.
Can I buy Fibrocor Therapeutics stock?
Fibrocor Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fibrocor Therapeutics's last funding round?
Fibrocor Therapeutics's most recent funding round was Strategic on January 15, 2020.
Who are the main investors in Fibrocor Therapeutics?
Key investors in Fibrocor Therapeutics include TIAP, BioGeneration Ventures.
Will Fibrocor Therapeutics IPO soon?
No public IPO plans have been announced for Fibrocor Therapeutics.
How can I track Fibrocor Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Fibrocor Therapeutics's shares on secondary markets.